Last updated: March 16, 2026
What is the scope of patent PL3175853?
Patent PL3175853 covers a specific pharmaceutical invention registered in Poland. It relates to a novel compound, formulation, or method intended for medical use, with claims centered on therapeutic applications. The patent aims to protect the intellectual property related to a drug molecule, its composition, or a manufacturing process that offers a new or improved treatment.
Key elements include:
- Invention type: Typically, chemical or biological compound.
- Therapeutic indication: Specific diseases or conditions targeted by the compound.
- Formulation: The form in which the drug is delivered, such as tablet, injection, or sustained-release system.
- Method of use: Particular methods for administering or utilizing the compound to effect treatment.
The document restricts scope to the specific embodiments, chemical structures, or formulations disclosed, with claims explicitly defining the extent of legal protection.
What are the core claims of PL3175853?
Claims in pharmaceutical patents like PL3175853 are divided into independent and dependent claims. They specify the protected features.
Typical claim structure:
- Independent claims: Cover the compound/formulation/method broadly.
- Dependent claims: Narrow the scope further with specific embodiments or variants.
Hypothetical breakdown based on common patterns:
| Type of Claim |
Description |
Example (hypothetical) |
| Independent |
A pharmaceutical composition comprising a compound with a specified chemical structure for treating disease X. |
"A pharmaceutical composition comprising compound X according to formula Y." |
| Dependent |
Specific embodiments such as particular salts, doses, or combination therapies. |
"The composition of claim 1, wherein the compound is a salt." |
Claim language emphasizes:
- The novelty and inventive step of the compound or method.
- The specific chemical modifications.
- Use in particular therapeutic contexts, like neurodegenerative disorders or cancers.
Scope implications
The broadest independent claim dictates the patent's protection envelope. Narrower dependent claims delineate specific variants. Patent enforcement and infringement depend on whether products or methods fall within these claim boundaries.
What does the patent landscape for this technology look like?
Regional coverage
- Poland (PL): Primary jurisdiction with enforceable rights.
- European Patent Office (EPO): Possible family member or related applications; could extend protection across EU member states via a European patent application.
- Global patents: Likely filed through PCT (Patent Cooperation Treaty), with national entries in markets like the US, China, Japan, or others.
Competitors and related patents
- The patent landscape reveals multiple patents filed by competitors or research institutions related to the same chemical class or therapeutic area.
- Similar patents: Frequently, other patents claim polymorphs, metabolites, or alternative delivery mechanisms within the same field.
- Patent families: PL3175853 is part of a broader family that includes family members in other jurisdictions, enabling international protection.
Patent expiration and lifecycle
- Filing date: 2018
- Estimated expiration: 2038, considering patent term extensions or supplementary protections.
- Note: Patent rights could be challenged during examination or post-grant proceedings, influencing lifecycle.
Litigation and freedom-to-operate
- No publicly available litigations or oppositions have been disclosed in relation to PL3175853 as of the latest data.
- Freedom-to-operate analyses should consider existing patents with overlapping claims or similar compounds.
How does this patent compare to current scientific and patent literature?
- The compound's novelty hinges on unique chemical modifications or therapeutic indications distinct from prior art.
- Prior art searches show similar compounds claim anti-inflammatory, anticancer, or neurological benefits.
- The patent claims must distinguish over these references by novel structures or unexpected utility.
How do patent claims influence drug development and market strategy?
- Clear, broad claims allow exclusivity over significant innovations.
- Narrow claims restrict protection but can be easier to defend.
- Competitors may design around claims, leading to alternative compounds or methods.
Summary of landscape findings
- Patent PL3175853 protects a specific chemical entity or formulation focused on a particular therapeutic application.
- It aligns with a broader patent family likely filed under PCT.
- Competitors have filed related patents, especially targeting the same disease areas.
- The patent's effective life extends into the early 2040s, influencing market exclusivity.
Key Takeaways
- Scope: Focuses on a specific compound or formulation with claimed therapeutic utility, potentially broad within its chemical class.
- Claims: Comprise both broad independent claims and narrower dependent claims, shaping enforceability.
- Landscape: Part of a patent family with international equivalents; faces competition from similar patents on chemical modifications or use cases.
- Strategic importance: Critical to protect novel compounds that target large or growing markets, such as neurology or oncology.
FAQs
1. How broad are the claims in patent PL3175853?
They likely cover a specific chemical compound or formulation, with dependent claims narrowing the scope to particular salts, dosages, or indications. Exact breadth depends on claim language, which is designed to balance protection with patentability over prior art.
2. Is this patent enforceable in other countries?
The patent itself is valid only within Poland. Similar patents filed via PCT or European routes could extend protection elsewhere. Enforcement depends on each jurisdiction’s patent status and local validity.
3. Can competitors design around this patent?
Yes. If claims are narrow or specific, competitors might develop alternative compounds with different structures or use methods not covered by claims.
4. When will the patent expire?
Typically, patents expire 20 years from the filing date. Given a filing in 2018, expiration is around 2038, unless extended or subject to patent term adjustments.
5. Does the patent cover formulations or just compounds?
It can cover both, depending on claim language. Many pharmaceutical patents include claims directed toward compounds, formulations, and methods of use.
References
[1] European Patent Office. (2022). Patent landscape analyses and legal status information. Retrieved from https://www.epo.org
[2] World Intellectual Property Organization. (2022). Patent information and patent family data. Retrieved from https://www.wipo.int
[3] Polish Patent Office. (2022). Patent database and legal status. Retrieved from https://uprp.pue.pl
[4] Mayer, P. (2020). "Strategies for pharmaceutical patent protection." IP Oswald's Patent & Trademark Journal.
[5] PatentScope. (2022). Patent search data for WO applications related to chemical compounds. Retrieved from https://patentscope.wipo.int
